Kovacs Shane William Charles - Net Worth and Insider Trading
Kovacs Shane William Charles Net Worth
The estimated net worth of Kovacs Shane William Charles is at least $5 Million dollars as of 2024-11-13. Kovacs Shane William Charles is the CH. OPERATING & FINANCIAL OFF. of Olema Pharmaceuticals inc and owns about 424,987 shares of Olema Pharmaceuticals inc (OLMA) stock worth over $5 Million. Kovacs Shane William Charles is also the CFO of PTC Therapeutics Inc and owns about 8,850 shares of PTC Therapeutics Inc (PTCT) stock worth over $394,887. Details can be seen in Kovacs Shane William Charles's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kovacs Shane William Charles has not made any transactions after 2023-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kovacs Shane William Charles
Kovacs Shane William Charles Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kovacs Shane William Charles owns 2 companies in total, including PTC Therapeutics Inc (PTCT) , and Olema Pharmaceuticals inc (OLMA) .
Click here to see the complete history of Kovacs Shane William Charles’s form 4 insider trades.
Insider Ownership Summary of Kovacs Shane William Charles
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 2017-01-03 | Chief Financial Officer |
| OLMA | Olema Pharmaceuticals inc | 2023-11-22 | Ch. Operating & Financial Off. |
Kovacs Shane William Charles Latest Holdings Summary
Kovacs Shane William Charles currently owns a total of 2 stocks. Among these stocks, Kovacs Shane William Charles owns 424,987 shares of Olema Pharmaceuticals inc (OLMA) as of November 22, 2023, with a value of $5 Million and a weighting of 92.55%. Kovacs Shane William Charles also owns 8,850 shares of PTC Therapeutics Inc (PTCT) as of May 22, 2015, with a value of $394,887 and a weighting of 7.45%.
Latest Holdings of Kovacs Shane William Charles
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals inc | 2023-11-22 | 424,987 | 11.54 | 4,904,350 |
| PTCT | PTC Therapeutics Inc | 2015-05-22 | 8,850 | 44.62 | 394,887 |
Holding Weightings of Kovacs Shane William Charles
Kovacs Shane William Charles Form 4 Trading Tracker
According to the SEC Form 4 filings, Kovacs Shane William Charles has made a total of 2 transactions in Olema Pharmaceuticals inc (OLMA) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Olema Pharmaceuticals inc is the sale of 18,742 shares on November 22, 2023, which brought Kovacs Shane William Charles around $269,697.
According to the SEC Form 4 filings, Kovacs Shane William Charles has made a total of 0 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years. The most-recent trade in PTC Therapeutics Inc is the sale of 82,491 shares on May 22, 2015, which brought Kovacs Shane William Charles around $5 Million.
Insider Trading History of Kovacs Shane William Charles
- 1
Kovacs Shane William Charles Trading Performance
GuruFocus tracks the stock performance after each of Kovacs Shane William Charles's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kovacs Shane William Charles is 174.47%. GuruFocus also compares Kovacs Shane William Charles's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kovacs Shane William Charles within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kovacs Shane William Charles's insider trading performs compared to the benchmark.
Performance of Kovacs Shane William Charles
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 102.43 | | | | | |
| Relative Return to S&P 500(%) | 101.67 | | | | | |
Kovacs Shane William Charles Ownership Network
Ownership Network List of Kovacs Shane William Charles
Ownership Network Relation of Kovacs Shane William Charles
Kovacs Shane William Charles Owned Company Details
What does PTC Therapeutics Inc do?
Who are the key executives at PTC Therapeutics Inc?
Kovacs Shane William Charles is the Chief Financial Officer of PTC Therapeutics Inc. Other key executives at PTC Therapeutics Inc include CHIEF FINANCIAL OFFICER Pierre Gravier , Chief Medical Officer Lee Scott Golden , and Chief Development Officer Matthew B. Klein .
PTC Therapeutics Inc (PTCT) Insider Trades Summary
Over the past 18 months, Kovacs Shane William Charles made no insider transaction in PTC Therapeutics Inc (PTCT). Other recent insider transactions involving PTC Therapeutics Inc (PTCT) include a net sale of 22,039 shares made by Eric Pauwels , a net sale of 22,455 shares made by Matthew B. Klein , and a net sale of 2,701 shares made by Lee Scott Golden .
In summary, during the past 3 months, insiders sold 0 shares of PTC Therapeutics Inc (PTCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114,302 shares of PTC Therapeutics Inc (PTCT) were sold and 7,700 shares were bought by its insiders, resulting in a net sale of 106,602 shares.
PTC Therapeutics Inc (PTCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
PTC Therapeutics Inc Insider Transactions
Kovacs Shane William Charles Mailing Address
Above is the net worth, insider trading, and ownership report for Kovacs Shane William Charles. You might contact Kovacs Shane William Charles via mailing address: Ptc Therapeutics, Inc., 100 Corporate Court, South Plainfield Nj 07080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
